Brainstorm Cell Lawsuit Submission Form

Company: Brainstorm Cell Therapeutics Inc.

Ticker: (NASDAQ) BCLI

Deadline

Passed

Lead Plaintiff Deadline: January 02, 2024

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines.

WhatsApp

WhatsApp Channel QR Code

Scan the QR code or click the button to join.

Get Updates by Email

Subscribe for email notifications.

No spam, opt-out anytime, alert list is free.

Allegations

The filed complaint alleges that Brainstorm Cell Therapeutics Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Brainstorm Cell downplayed the severity of the refusal to file letter it received from the U.S. Food and Drug Administration regarding NurOwn ; (2) Brainstorm Cell continued to conceal the risks associated with the submission of the Biologics License Application for NurOwn; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.